Mandate

Vinge advises the Swedish government’s venture capital company, Fouriertransform

October 29, 2009

Vinge is assisting the Swedish government’s venture capital company for the automotive industry, Fouriertransform, in relation to its first investment. Fouriertransform has been formed to assist the automotive industry and is expected to make fifty investments within the next 15 months.

SEK 60 million is to be invested in Powercell Sweden AB which develops, produces and sells fuel cells, fuel reformers and auxillary power units.

Fouriertransform’s investment is occurring through a directed issue of new shares. Through Volvo Technology Transfer, AB Volvo remains the largest shareholder in Powecell Sweden AB with more than 40 per cent of the shares.

The Vinge team consisted of Ulf Sallnäs and Helena Jonsson.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026